Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service decompression & minimally invasive spine cases in Kentucky: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (250 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 45 | 2,406 | 37% |
| 2020 | 37 | 1,726 | 41% |
| 2021 | 35 | 1,676 | 47% |
| 2022 | 36 | 1,658 | 52% |
| 2023 | 25 | 1,336 | 55% |
| 2024 | 33 | 1,469 | 57% |
| 2025 from claims | – | 1,505 1,381–1,593 | 58% |
| 2026 forecast | – | 1,502 1,321–1,733 | 59% |
| 2027 forecast | – | 1,503 1,285–1,791 | 60% |
| 2028 forecast | – | 1,503 1,254–1,840 | 60% |
| 2029 forecast | – | 1,503 1,227–1,885 | 61% |
| 2030 forecast | – | 1,502 1,204–1,925 | 62% |
Laminotomy, laminectomy, interspinous devices; the MIS call point. Professional codes (what the surgeon bills): CPT 63030, 63047, 63020, 63045, 22867; the hospital bills MS-DRG 518, 519, 520.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 54% of the cases CMS names in Kentucky; 21 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 46% inpatient hospital, 52% hospital outpatient, 1% surgery center.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Texas | 195 | 8,404−6.2%/yr | −6.2%/yr | 3.8 | 4% | 9,180 in 2030+1.5%/yr |
| Florida | 167 | 7,562−4%/yr | −4%/yr | 3.3 | 15% | 8,490 in 2030+1.9%/yr |
| North Carolina | 90 | 3,162−8.5%/yr | −8.5%/yr | 3.1 | 17% | 3,120 in 2030−0.2%/yr |
| Virginia | 64 | 2,968−6.1%/yr | −6.1%/yr | 2.8 | 2% | 3,270 in 2030+1.7%/yr |
| Tennessee | 70 | 2,945−5.3%/yr | −5.3%/yr | 4.0 | 12% | 3,010 in 2030+0.4%/yr |
| Maryland | 71 | 2,940−4.2%/yr | −4.2%/yr | 3.3 | 5% | 3,010 in 2030+0.4%/yr |
| Georgia | 72 | 2,880−6.9%/yr | −6.9%/yr | 3.2 | 7% | 3,140 in 2030+1.5%/yr |
| South Carolina | 56 | 2,163−7.6%/yr | −7.6%/yr | 3.1 | 7% | 2,560 in 2030+2.8%/yr |
| Oklahoma | 44 | 1,608−8.9%/yr | −8.9%/yr | 3.2 | 1% | 1,650 in 2030+0.4%/yr |
| Alabama | 39 | 1,508−11%/yr | −11%/yr | 3.3 | 4% | 1,590 in 2030+0.9%/yr |
| Louisiana | 29 | 1,488−6.6%/yr | −6.6%/yr | 3.5 | 5% | 1,490 in 2030+0.1%/yr |
| Arkansas | 30 | 1,254−7.9%/yr | −7.9%/yr | 3.2 | 7% | 1,220 in 2030−0.4%/yr |
| Mississippi | 19 | 811−12%/yr | −12%/yr | 2.1 | 24% | 720 in 2030−2%/yr |
| Delaware | 11 | 619+0.2%/yr | +0.2%/yr | 3.5 | 16% | 820 in 2030+4.7%/yr |
| District of Columbia | 9 | 350−0.3%/yr | −0.3%/yr | 5.4 | 8% | 320 in 2030−1.3%/yr |
| West Virginia | 6 | 276−14%/yr | −14%/yr | 1.3 | 0% | 310 in 2030+2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 33 | 1,251−4%/yr | −4%/yr | 2.60.8× | 1% | 1,500 in 2030+3.1%/yr |
| Cervical fusion & disc arthroplasty | 10 | 605−9.7%/yr | −9.7%/yr | 1.30.7× | 2% | 730 in 2030+3.1%/yr |
| Kyphoplasty & vertebroplasty | 5 | 575−12%/yr | −12%/yr | 1.20.7× | 21% | 690 in 2030+3%/yr |
| SI joint fusion | 2 | 100−6.4%/yr | −6.4%/yr | 0.20.6× | 0% | 170 in 2030+8.9%/yr |
Decompression & minimally invasive spine in every state, and its device makers · Every procedure market in Kentucky · Every state · Compare with Texas
Medtronic leads with 42% of company spending on these surgeons in 2025, −40 pts on 2024.
In 2025, 7 companies reported engagement with Kentucky’s surgeons worth $43K in consulting, speaking, meals and travel tied to these products, about $1,317 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 5 clearances and approvals in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.